Principles of disease management in neonatology

Pediatric Clinics of North America
F W Bowen, S Gwiazdowski

Abstract

This article emphasizes the emerging facets of disease-management practice that impact directly on establishing a measured care system that can produce the information needed to establish a continuous quality improvement program. The areas discussed are risk assessment, clinical management guidelines and carepaths, and the measurement of system output known as clinical outcomes. The remainder of the article details the aspects of risk assessment, guideline function, and outcome assessment, critical in a disease-managed measured care system.

References

Jan 1, 1992·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·H Griffith, I Miller
Jan 1, 1991·American Journal of Public Health·L I IezzoniM A Moskowitz
Jan 1, 1990·International Journal of Technology Assessment in Health Care·L I Iezzoni
Apr 1, 1989·American Journal of Public Health·E L HannanH Kilburn
Jan 1, 1989·Health Affairs·B Steinwald, L A Dummit
Jan 1, 1989·Journal of Clinical Epidemiology·L L RoosA Wajda
Jan 1, 1989·Journal of Clinical Epidemiology·R A BrightD E Everitt
Jan 5, 1989·The New England Journal of Medicine·D M Berwick
Mar 2, 1989·The New England Journal of Medicine
Feb 1, 1986·Medical Care·S D Horn, R A Horn
Jan 1, 1986·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D H GustafsonJ Moore
May 1, 1986·American Journal of Public Health·S D HornH Moses
Aug 1, 1987·Critical Care Medicine·S LemeshowH Pastides
Sep 10, 1987·The New England Journal of Medicine·S F Jencks, A Dobson
Nov 3, 1988·The New England Journal of Medicine·A S Relman
Oct 9, 1986·The New England Journal of Medicine·D BrootenM Delivoria-Papadopoulos
Jan 1, 1987·Annual Review of Public Health·F A ConnellL G Hart
Oct 1, 1987·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J C Hershey, J Baron
Dec 24, 1987·The New England Journal of Medicine·R W DuboisR H Brook
Jan 1, 1986·Health Affairs·H Taylor, M Kagay
Jan 15, 1987·The New England Journal of Medicine·M M PollackP R Getson
Oct 1, 1985·American Journal of Public Health·S D HornR A Horn
Apr 1, 1985·Annals of Internal Medicine·S GreenfieldJ E Ware
Mar 21, 1968·The New England Journal of Medicine·L L Weed
Mar 14, 1968·The New England Journal of Medicine·L L Weed
May 1, 1982·Medical Care·W W YoungD M Zorn
Nov 1, 1980·Annals of Internal Medicine·D S Brody
Nov 1, 1995·Obstetrics and Gynecology·M A BlegenR R Murphy
Jan 1, 1995·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·K N Lohr
Feb 1, 1995·AACN Clinical Issues·N Urban
Jan 1, 1995·American Journal of Medical Quality : the Official Journal of the American College of Medical Quality·M B Kapp
Oct 1, 1994·The Pediatric Infectious Disease Journal·G J EscobarB Folck

❮ Previous
Next ❯

Citations

Feb 9, 2005·Seminars in Fetal & Neonatal Medicine·Aung Soe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.